{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:49:10Z","timestamp":1782344950345,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116480","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T08:39:29Z","timestamp":1711528769000},"page":"116480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Treatment with bestatin (the exogenous synthetic inhibitor of metalloproteinases) reduces the activity of metalloproteinase 2 and 12 in the spleen and lung tissues of rats in a model of lipopolysaccharide-induced sepsis"],"prefix":"10.1016","volume":"174","author":[{"given":"Barbara","family":"Nieradko-Iwanicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Piasecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Borz\u0119cki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.116480_bib1","first-page":"67","article-title":"Sepsis definition: what's new in the treatment guidelines","volume":"61","author":"Srzi\u0107","year":"2022","journal-title":"Acta Clin. Croat."},{"issue":"4","key":"10.1016\/j.biopha.2024.116480_bib2","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20198595","article-title":"Sepsis: evolving concepts and challenges","volume":"52","author":"Salom\u00e3o","year":"2019","journal-title":"Braz. J. Med Biol. Res"},{"issue":"2","key":"10.1016\/j.biopha.2024.116480_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/biom12020279","article-title":"Genetic variants of matrix metalloproteinase and sepsis: the need speed study","volume":"12","author":"Fiotti","year":"2022","journal-title":"Biomolecules"},{"issue":"17","key":"10.1016\/j.biopha.2024.116480_bib4","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.3390\/ijms20174194","article-title":"Conformation and domain movement analysis of human matrix metalloproteinase-2: role of associated Zn2+ and Ca2+ Ions","volume":"20","author":"Voit-Ostricki","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116480_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113623","article-title":"Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies","volume":"223","author":"Das","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116480_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113044","article-title":"Outline of gelatinase inhibitors as anti-cancer agents: a patent mini-review for 2010-present","volume":"213","author":"Baidya","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"31","key":"10.1016\/j.biopha.2024.116480_bib7","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1021\/bi700541p","article-title":"Molecular dynamics simulations of matrix metalloproteinase 2: role of the structural metal ions","volume":"46","author":"D\u00edaz","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2024.116480_bib8","article-title":"Implications of MMP-12 in the pathophysiology of ischaemic stroke","author":"Veeravalli","year":"2023","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.biopha.2024.116480_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113623","article-title":"Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies","volume":"223","author":"Das","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116480_bib10","article-title":"Synthesis of (-)-Bestatin. Synthesis of natural products and potential","volume":"1","author":"Liu","year":"2010","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.biopha.2024.116480_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijmm.2007.04.001","article-title":"Structural biology of the LPS recognition","volume":"297","author":"Jerala","year":"2007","journal-title":"Int J. Med. Microbiol"},{"issue":"2","key":"10.1016\/j.biopha.2024.116480_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/ACO.0000000000000963","article-title":"Pathophysiology of sepsis","volume":"34","author":"Arina","year":"2021","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116480_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1389200013338748","article-title":"Bestatin as an experimental tool in mammals","volume":"2","author":"Scornik","year":"2001","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.116480_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/med.20044","article-title":"Aminopeptidase-N\/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects","volume":"26","author":"Bauvois","year":"2006","journal-title":"Med Res Rev."},{"key":"10.1016\/j.biopha.2024.116480_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3827501","article-title":"Lidocaine alleviates sepsis-induced acute lung injury in mice by suppressing tissue factor and matrix metalloproteinase-2\/9","volume":"2021","author":"Zheng","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2024.116480_bib16","unstructured":"Zhang X.F., Zhu G.F., Liu S., Foda H.D. The role of disequilibrium of expression of matrix metalloproteinase-2\/9 and their tissue inhibitors in pathogenesis of hyperoxia-induced acute lung injury in mice]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Oct;20(10):597-600. Chinese. PMID: 18926070."},{"key":"10.1016\/j.biopha.2024.116480_bib17","unstructured":"Liu C.J., Xu F., Kuang F.W., Dang R., Lu Z.Y., Wang X.Y. Study on effect of dexamethasone on the expression of matrix metalloproteinase and its tissue inhibitors in hyperoxia-induced lung injury]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Oct;16(10):618-21. Chinese. PMID: 15461845."},{"issue":"10141","key":"10.1016\/j.biopha.2024.116480_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biopha.2024.116480_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/339549","article-title":"Clinical trials of immunomodulatory therapies in severe sepsis and septic shock","volume":"34","author":"Vincent","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"15","key":"10.1016\/j.biopha.2024.116480_bib20","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1089\/ars.2021.0027","article-title":"Oxidative stress and endothelial dysfunction in sepsis and acute inflammation","volume":"35","author":"Joffre","year":"2021","journal-title":"Antioxid. Redox Signal"},{"issue":"1","key":"10.1016\/j.biopha.2024.116480_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.biopha.2024.116480_bib22","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1021\/pr3005666","article-title":"Proteomic evaluation of inflammatory proteins in rat spleen interstitial fluid and lymph during LPS-induced systemic inflammation reveals increased levels of ADAMST1","volume":"11","author":"Oveland","year":"2012","journal-title":"J. Proteome Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116480_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5487\/TR.2018.34.1.065","article-title":"Pretreatment of low-dose and super-low-dose LPS on the production of in vitro LPS-induced inflammatory mediators","volume":"34","author":"Chae","year":"2018","journal-title":"Toxicol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116480_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10408363.2013.764490","article-title":"Biomarkers of sepsis","volume":"50","author":"Faix","year":"2013","journal-title":"Crit. Rev. Clin. Lab Sci."},{"issue":"7-8","key":"10.1016\/j.biopha.2024.116480_bib25","first-page":"16290","article-title":"Surviving Sepsis Campaign Guidelines 2021: highlights for the practicing clinician","volume":"132","author":"Oczkowski","year":"2022","journal-title":"Pol. Arch. Intern Med"},{"key":"10.1016\/j.biopha.2024.116480_bib26","first-page":"793","article-title":"Altered brain metabolism of iron as a cause of neurodegenerative diseseases? J. Neurochem","volume":"63","author":"Gerlach","year":"1994"},{"issue":"143","key":"10.1016\/j.biopha.2024.116480_bib27","first-page":"419","article-title":"Estimation of protective effect of lipoic acid in the brain of rats during lipopolysaccharide-induced oxidative stress.","volume":"24","author":"Goraca","year":"2008","journal-title":"Pol. Merkur Lek."},{"issue":"9","key":"10.1016\/j.biopha.2024.116480_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/10408444.2015.1074159","article-title":"Free radicals and related reactive species as mediators of tissue injury and disease: implications for Health","volume":"45","author":"Kehrer","year":"2015","journal-title":"Crit. Rev. Toxicol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116480_bib29","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1161\/01.STR.29.10.2189","article-title":"Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain","volume":"29","author":"Rosenberg","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2024.116480_bib30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2013.06.034","article-title":"The roles of MMP-9\/TIMP-1 in cerebral edema following experimental acute cerebral infarction in rats","volume":"550","author":"Li","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2024.116480_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1902\/jop.1993.64.5.474","article-title":"Role of matrix metalloproteinases in human periodontal diseases","volume":"64","author":"Birkedal-Hansen","year":"1993","journal-title":"J. Periodo"},{"issue":"2","key":"10.1016\/j.biopha.2024.116480_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/CMR.00047-08","article-title":"Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock","volume":"22","author":"Vanlaere","year":"2009","journal-title":"Clin. Microbiol Rev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116480_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0765.1993.tb01082.x","article-title":"Inhibition of epithelial cell matrix metalloproteinases by tetracyclines","volume":"28","author":"Nip","year":"1993","journal-title":"J. Periodontal Res"},{"issue":"5","key":"10.1016\/j.biopha.2024.116480_bib34","first-page":"467","article-title":"Regulation of monocyte\/macrophage metalloproteinase production by cytokines","volume":"64","author":"Wahl","year":"1993","journal-title":"J. Periodo"},{"issue":"1","key":"10.1016\/j.biopha.2024.116480_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/prd.12035","article-title":"Matrix metalloproteinase processing of signaling molecules to regulate inflammation","volume":"63","author":"Butler","year":"2013","journal-title":"Periodontol 2000"},{"issue":"1","key":"10.1016\/j.biopha.2024.116480_bib36","first-page":"63","article-title":"Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis.","volume":"39","author":"Kurzepa","year":"2005","journal-title":"Neurol. Neurochir. Pol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116480_bib37","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1227\/01.NEU.0000351768.11363.48","article-title":"Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury","volume":"65","author":"Grossetete","year":"2009","journal-title":"Neurosurgery"},{"issue":"8","key":"10.1016\/j.biopha.2024.116480_bib38","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res"},{"issue":"4","key":"10.1016\/j.biopha.2024.116480_bib39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.HYP.0000014506.13322.66","article-title":"Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging","volume":"39","author":"Wang","year":"2002","journal-title":"Hypertension"},{"issue":"2-3","key":"10.1016\/j.biopha.2024.116480_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0753-3322(91)90122-A","article-title":"Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function","volume":"45","author":"Math\u00e9","year":"1991","journal-title":"Biomed. Pharm."},{"issue":"2-3","key":"10.1016\/j.biopha.2024.116480_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0753-3322(91)90123-B","article-title":"Review of ubenimex (Bestatin): clinical research","volume":"45","author":"Ota","year":"1991","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116480_bib42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mvr.2011.05.008","article-title":"LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo","volume":"82","author":"Gao","year":"2011","journal-title":"Micro Res"},{"issue":"5","key":"10.1016\/j.biopha.2024.116480_bib43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1160\/TH03-03-0144","article-title":"Aminopeptidase inhibitor bestatin stimulates microvascular endothelial cell invasion in a fibrin matrix","volume":"90","author":"van Hensbergen","year":"2003","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.biopha.2024.116480_bib44","first-page":"771","article-title":"FASN Inhibitors Enhance Bestatin-Related Tumor Cell Apoptosis Through Upregulating PEPT1","volume":"16","author":"Ni","year":"2023","journal-title":"Curr. Mol. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2024.116480_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01606-22","article-title":"Antiplasmodial activity evaluation of a bestatin-related aminopeptidase inhibitor, phebestin","volume":"67","author":"Ariefta","year":"2023","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:20:29Z","timestamp":1782343229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":45,"alternative-id":["S0753332224003640"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116480","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with bestatin (the exogenous synthetic inhibitor of metalloproteinases) reduces the activity of metalloproteinase 2 and 12 in the spleen and lung tissues of rats in a model of lipopolysaccharide-induced sepsis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116480"}}